A University of Chicago Consortium Phase II Trial of SB-715992 in Advanced Renal Cell Cancer

BACKGROUND: Advanced renal cell cancer (RCC) continues to have a poor overall prognosis despite new FDA-approved therapies. Although taxane-based therapies are generally ineffective in RCC, research into the role of the von Hippel-Lindau protein has shown an association with microtubule dynamics. Mi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lee, Richard T., Beekman, Kathleen E., Hussain, Maha, Davis, Nancy B., Clark, Joseph I., Thomas, Sachdev P., Nichols, Katherine F., Stadler, Walter M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2008
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2704464/
https://ncbi.nlm.nih.gov/pubmed/18501078
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak